Evidence map›Paper›PMID 24658280›Full record

ArticleOncotarget2014

HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation.

Charles Cobbs, Sabeena Khan, Lisa Matlaf, Sean McAllister, Alex Zider, Garret Yount, Kenneth Rahlin, Lualhati Harkins, Vladimir Bezrookove, Eric Singer and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Charles CobbsCalifornia Pacific Medical Center Research Institute, San Francisco, CA.
Sabeena Khan
Lisa Matlaf
Sean McAllister
Alex Zider
Garret Yount
Kenneth Rahlin
Lualhati Harkins
Vladimir Bezrookove
Eric Singer
Liliana Soroceanu
California Pacific Medical Center · USSwedish Medical Center · USUniversity of Alabama at Birmingham · US

Funding

Cytomegalovirus Gene Expression and Strain Variability in Glioma PathogenesisR01NS070289 · NINDS · SWEDISH MEDICAL CENTER, FIRST HILL · PI COBBS, CHARLES S · 2010 to 2014
$1.9M
Modulation of Glioma Growth and Invasion by HCMV Glycoprotein BR21NS067395 · NINDS · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI SOROCEANU, LILIANA · 2009 to 2010
$462k
NINDS NIH HHS R01 NS070289NINDS NIH HHS R01NS070289NINDS NIH HHS R21 NS067395NINDS NIH HHS R21NS067395
6 · The paper itself

Abstract

Our laboratory first demonstrated that human cytomegalovirus (HCMV) is associated with the most deadly form of primary brain tumor, glioblastoma (GBM). We showed that HCMV glycoprotein B (gB) mediates viral cellular entry via the receptor tyrosine kinase PDGFR-alpha (PDGFRα), resulting in activation of the PI3K/Akt pathway, a critical signaling axis gliomagenesis. Here, we investigated the effects of gB overexpression on glioma progression. We demonstrate that gB is endogenously expressed in primary GBM samples and show that ectopic gB expression in glioma cells induced sustained phosphorylation of PDGFRα, Akt, and Src. Recombinant gB protein and the whole virus enhanced invasion of primary glioblastoma cells into Matrigel and rat brain slices, and this effect was specifically inhibited by neutralizing antibodies to either gB or PDGFRα. Importantly, neutralizing antibodies to gB significantly inhibited the invasiveness of patient-derived HCMV-positive glioblastoma cells, suggesting that functional inhibition of this viral protein could hinder glioblastoma progression. gB overexpression promoted in vivo glioma growth and enhanced phosphor-Akt levels and tumor cell dispersal relative to controls. Taken together, our results demonstrate that HCMV gB promotes key hallmarks of glioblastoma and suggest that targeting gB may have therapeutic benefits for patients with HCMV-positive gliomas.

Indexed as

AnimalsBrain NeoplasmsCell Line, TumorCell MovementCytomegalovirusCytomegalovirus InfectionsFemaleGlioblastomaHeterograftsHumansMiceMice, NudeNeoplasm InvasivenessRatsReceptor, Platelet-Derived Growth Factor alphaSignal Transductionglycoprotein B, SimplexvirusReceptor, Platelet-Derived Growth Factor alphaViral Envelope Proteins

Identifiers

PMID24658280
PMCPMC4011586
OpenAlexW2102578228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.